BioNTech may be at least 32 times less effective in handling the new Omicron variant, a new study has found. Photo: May Tse
BioNTech may be at least 32 times less effective in handling the new Omicron variant, a new study has found. Photo: May Tse

Coronavirus: BioNTech vaccine could be much less effective against Omicron, Hong Kong research team finds

  • Inoculation remains only effective way to protect against Covid-19, university researchers say, urging elderly and other high-risk groups to get booster shots
  • Little known so far about new variant’s severity, though early data from South Africa shows low rate of hospitalisation

BioNTech may be at least 32 times less effective in handling the new Omicron variant, a new study has found. Photo: May Tse
BioNTech may be at least 32 times less effective in handling the new Omicron variant, a new study has found. Photo: May Tse
READ FULL ARTICLE